Furthermore, the obtainedresults in this study are compatible withthe findings of previous research regarding thedecreasing impact of adiponectin on the viabilityof various cancer cells such as breast cancer cellline (MCF7), prostate, endothelial cancer and bonecells (26-29). This evidence concerns the gene ADIPOQ and breast cancer.